Related Experiment Video
Updated: May 3, 2026
Author Spotlight: Studying Behavior of Acanthamoeba to Develop Targeted Strategies for Preventing Acanthamoeba Keratitis
Published on: September 20, 2024
Evaluation of Acanthamoeba myosin-IC as a potential therapeutic target
Carmen M Martín-Navarro1, Jacob Lorenzo-Morales, Atteneri López-Arencibia
1University Institute of Tropical Diseases and Public Health of the Canary Islands, University of La Laguna, Canary Islands, Spain.
Abstract:
Members of the genus Acanthamoeba are facultative pathogens of humans, causing a sight-threatening keratitis and a fatal encephalitis. We have targeted myosin-IC by using small interfering RNA (siRNA) silencing as a therapeutic approach, since it is known that the function of this protein is vital for the amoeba. In this work, specific siRNAs against the Acanthamoeba myosin-IC gene were developed. Treated and control amoebae were cultured in growth and encystment media to evaluate the induced effects after myosin-IC gene knockdown, as we have anticipated that cyst formation may be impaired. The effects of myosin-IC gene silencing were inhibition of cyst formation, inhibition of completion of cytokinesis, inhibition of osmoregulation under osmotic stress conditions, and death of the amoebae. The finding that myosin-IC silencing caused incompletion of cytokinesis is in agreement with earlier suggestions that the protein plays a role in cell locomotion, which is necessary to pull daughter cells apart after mitosis in a process known as "traction-mediated cytokinesis". We conclude that myosin-IC is a very promising potential drug target for the development of much-needed antiamoebal drugs and that it should be further exploited for Acanthamoeba therapy.
Insights
Small interfering RNA (siRNA) silencing of Acanthamoeba myosin-IC inhibits cyst formation, cell division, and osmoregulation, leading to amoeba death. This highlights myosin-IC as a promising drug target for treating Acanthamoeba infections.
Area of Science:
- * Molecular biology
- * Parasitology
- * Drug discovery
Background:
- * Acanthamoeba species are opportunistic human pathogens causing severe keratitis and encephalitis.
- * Myosin-IC is essential for amoeba viability and function.
- * Current treatments for Acanthamoeba infections are limited.
Purpose of the Study:
- * To investigate the therapeutic potential of targeting Acanthamoeba myosin-IC using small interfering RNA (siRNA).
- * To evaluate the effects of myosin-IC gene knockdown on Acanthamoeba growth, encystment, and survival.
Main Methods:
- * Development and application of specific siRNAs targeting the Acanthamoeba myosin-IC gene.
- * Culture of treated and control amoebae in growth and encystment media.
- * Assessment of phenotypic changes following myosin-IC gene silencing.
Main Results:
- * siRNA-mediated myosin-IC knockdown significantly inhibited cyst formation.
- * Silencing of myosin-IC impaired the completion of cytokinesis, consistent with its role in traction-mediated cytokinesis.
- * Acanthamoeba exhibited compromised osmoregulation under osmotic stress.
- * Myosin-IC gene silencing led to amoeba death.
Conclusions:
- * Acanthamoeba myosin-IC is a crucial protein for multiple essential cellular processes, including cytokinesis, osmoregulation, and survival.
- * Myosin-IC is a highly promising drug target for developing novel antiamoebal therapies.
- * Further research into myosin-IC as a therapeutic target is warranted for Acanthamoeba infections.
More Related Videos
10:28A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
Published on: August 17, 2019
06:51Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
Related Concept Videos
01:15Anthelminthic Agents
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...